Example: Heart Attack

Clinical Trials Sponsored by GlaxoSmithKline

Total 4645 results

NCT05879107

Not yet recruiting

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

Respiratory Syncytial Virus Infections
NCT05879419

Recruiting

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases (RZVRheum)

Rheumatoid Arthritis Systemic Lupus Erythematosus Systemic Sclerosis Juvenile Idiopathic Arthritis Sjogren's Syndrome Spondylitis, Ankylosing Spondyloarthritis Idiopathic Inflammatory Myopathies Vasculitis, Systemic Dermatomyositis, Juvenile
NCT05878717

Not yet recruiting

A Study of the Efficiency And Safety Study of Belimumab Compared To Placebo In Adults With Systemic Sclerosis Associated Interstitial Lung Disease (BLISSc-ILD)

Systemic Sclerosis Associated Interstitial Lung Disease
NCT05857397

Not yet recruiting

A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America (CONOR)

Ovarian Cancer
NCT05855200

Not yet recruiting

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer (AZUR-2)

Colonic Neoplasms
NCT05855811

Not yet recruiting

PREventing Second Cancers With DOSTARlimab (PREDOSTAR)

Recurrent Cancer Second Cancer Primary Cancer
NCT05838755

Not yet recruiting

A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain (NEPTUNE-17)

Pain
NCT05838742

Not yet recruiting

A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis Pain (MARS-17)

Pain
NCT05823974

Recruiting

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Influenza, Human
NCT05819892

Not yet recruiting

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Endometrial Cancer
NCT05811754

Not yet recruiting

Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions

Herpes Zoster
NCT05791565

Recruiting

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

Asthma
NCT05789303

Not yet recruiting

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

Multiple Myeloma Relapse Multiple Myeloma
NCT05784012

Not yet recruiting

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma (RADIAN)

Head and Neck Squamous Cell Carcinoma
NCT05775718

Not yet recruiting

Shingrix In Recipients of Allogeneic Transplants (Allo)

Stem Cell Transplant Bone Marrow Transplant
NCT05762861

Not yet recruiting

Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort (EPISODE)

COPD Exacerbation
NCT05757102

Not yet recruiting

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Asthma
NCT05721365

Not yet recruiting

The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) Setting

Cancer
NCT05723562

Recruiting

A Phase 2 Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)

Neoplasms, Rectal
NCT05718323

Not yet recruiting

Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC (RAISE)

SCLC,Extensive Stage SLFN11-positive
NCT05714839

Not yet recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (DREAMM-20)

Multiple Myeloma
NCT05705440

Recruiting

A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control

Respiratory Syncytial Virus Infections
NCT05694715

Recruiting

Combination Therapy in Cancers With Mutations in DNA Repair Genes

Metastatic Solid Tumor BRCA1 Mutation BRCA2 Mutation PALB2 Gene Mutation ATM Gene Mutation
NCT05682326

Not yet recruiting

Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) (ASCEND-P)

Anaemia
NCT05677347

Not yet recruiting

Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
NCT05673083

Recruiting

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

Multiple Myeloma Multiple Myeloma in Relapse Multiple Myeloma With Failed Remission Multiple Myeloma, Refractory
NCT05666349

Not yet recruiting

Reirradiation and Niraparib in Patients With Recurrent Glioblastoma (RiNG)

Recurrent Glioblastoma
NCT05659381

Not yet recruiting

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer (HOTT)

Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Stage III Ovarian Cancer Stage III Primary Peritoneal Cancer Stage III Fallopian Tube Cancer
NCT05660265

Not yet recruiting

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

Hematologic Diseases Anaemia, Sickle Cell
NCT05648357

Not yet recruiting

A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

Influenza, Human
NCT05630846

Recruiting

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles; Mumps; Rubella; Chickenpox
NCT05630859

Recruiting

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Sexually Transmitted Diseases
NCT05630833

Recruiting

A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis) (EAGLE-J)

Urinary Tract Infections
NCT05630820

Recruiting

Phase 3 Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) (B-Well 2)

Chronic Hepatitis B
NCT05630807

Recruiting

Phase 3 Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) (B-Well1)

Chronic Hepatitis B

Clinical Trials Sponsored by GlaxoSmithKline

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations